ClinicalTrials.Veeva

Menu

(TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury (AKI) in Aortic Surgery (TIGER)

J

Jörg Schefold

Status

Completed

Conditions

Renal Failure
Dialysis
Acute Kidney Injury
Biomarker
Aortic Surgery

Treatments

Other: does not apply

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

New biomarkers that predict the development of renal dysfunction in patients with aortic surgery are urgently needed. The investigators investigate whether urinary (TIMP-2)x(IGFBP7) predicts postoperative Acute Kidney Injury and/or need for Renal Replacement Therapy (RRT) in patients after aortic surgery (including EVAR).

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients in need of emergency or elective abdominal aortic surgery (infra- or suprarenal clamping or EVAR) are eligible for study inclusion.

Exclusion criteria

  • Patients unable to give informed consent
  • Age < 18
  • Patients not speaking German or French.

Trial design

100 participants in 1 patient group

Group of patients after aortic surgery
Description:
with subanalysis of patients with/without supra-/infrarenal surgery
Treatment:
Other: does not apply

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems